From Retirement To The Front Lines Of Hepatitis C Treatment
This doctor came out of retirement with the goal of treating every patient at high risk for hepatitis C he encounters. The problem is finding them.
Drugs
1,041 - 1,060 of 1,298 Results
-
-
Readers Have Bones To Pick, From Health System Flaws To Covering Pot Beat
Kaiser Health News gives readers a chance to comment on a recent batch of stories.
-
FDA Chief Says Hes Open To Rethinking Incentives On Orphan Drugs
The FDAs Scott Gottlieb says the agency is focused on the big picture, and he wants to know why pharma churns out drugs for some rare diseases but not for others.
-
Arthritis Drugs Show How U.S. Drug Prices Defy Economics
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
-
Biosimilars, Biologics And New Legal Challenges For RA Treatments
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
-
Unregulated Herpes Experiments Expose Black Hole Of Accountability
Controversial research methods by university researcher unlikely to prompt federal response or institutional change, experts say.
-
Arizona Declares Opioid Emergency, But Signals Are Mixed Over Best Response
Arizona is one of a few states that have declared the opioid epidemic a public health emergency. There's no uniformity in what that means from state to state, though, and even within Arizona, there's a wide divergence of opinion on how best to tackle the problem.
-
Drug Industry Spent Millions To Squelch Talk About High Drug Prices
Last year, the pharma industry biggest trade group raised millions to change the conversation about drug pricing.
By Jay Hancock -
Medicare Fails To Recover Hundreds Of Millions Of Dollars In Lab Overcharges
Genetic testing firms declare bankruptcy and wipe out debt to the federal government.
By Fred Schulte -
Experts Tell Congress How To Cut Drug Prices. We Give You Some Odds.
Some of the nations most influential scientists recommend eight steps to lower drug prices. KHN takes the political temperature and tells you the chances of Congress acting on them.
-
An Overlooked Epidemic: Older Americans Taking Too Many Unneeded Drugs
Researchers estimate that 25 percent of people ages 65 to 69 take at least five prescription drugs to treat chronic conditions. But some doctors are trying to teach others about deprescribing or systematically discontinuing medicines that are inappropriate, duplicative or unnecessary.
-
Cities, Counties and Schools Sidestep FDA Canadian Drug Crackdown, Saving Millions
Medicines are up to 80 percent cheaper north of the border and overseas, so U.S. localities are greasing a pharmaceutical pipeline that the feds warn is illegal and possibly unsafe.
-
Pace Of U.S. Health Spending Slows In 2016
Dramatic increases in spending that came with the influx of newly insured consumers in 2014 and 2015 appear to be moderating.
-
Stopping Opioid Addiction At One Key Source: The Hospital
Based on research conducted at the University of Michigans medical center, a group of surgeons developed a strategy to help post-surgical patients from misusing or abusing their prescription painkillers.
-
Texans With HIV Cope With Homes And Medicines Ruined By Hurricane Harvey
The hurricane closed pharmacies and clinics for a week or longer. Floodwaters spoiled drugs. People who fled to other states couldn't get their prescriptions filled for HIV medicine.
By Sarah Varney -
Congress Isnt Really Done With Health Care Just Look At Whats In The Tax Bills
Even though congressional Republicans set aside their Obamacare repeal-and-replace efforts this year, here are five major health policy changes that could become law as part of the pending House and Senate proposals.
By Julie Rovner -
Podcast: ‘What The Health?’ Taxes, Medicare And The Year-End Mess
In this episode of What the Health? Julie Rovner of Kaiser Health News, Joanne Kenen of Politico and Paige Winfield Cunningham of The Washington Post discuss the possible impact of the tax bill on the Medicare program, confirmation hearings for a new secretary of Health and Human Services and the future of the Childrens Health Insurance Program. Plus, for extra credit, the panelists recommend their favorite health stories of the week.
-
Patients With Rare Diseases And Congress Square Off Over Orphan Drug Tax Credits
The House and Senate want to reduce or eliminate federal tax credits for orphan drugs used to treat rare diseases, but patients are fighting against the plan.
-
University Was Tipped Off To Possible Unauthorized Trials Of Herpes Vaccine
Southern Illinois University has concluded its researcher violated university rules and U.S. law.
-
The Ratcheting Price Of The Pneumococcal Vaccine: What Gives?
The price for Pfizers Prevnar 13 has increased 5 to 6 percent each year since its 2010 approval by the Food and Drug Administration.